Wanner C - Search Results

1

Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.

Espe KM, Raila J, Henze A, Blouin K, Schneider A, Schmiedeke D, Krane V, Pilz S, Schweigert FJ, Hocher B, Wanner C, Drechsler C; German Diabetes and Dialysis Study Investigators. Espe KM, et al. Among authors: wanner c. Clin J Am Soc Nephrol. 2013 Mar;8(3):452-8. doi: 10.2215/CJN.04880511. Epub 2013 Jan 18. Clin J Am Soc Nephrol. 2013. PMID: 23335039 Free PMC article. Clinical Trial.

2

The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease.

Krane V, Wanner C. Krane V, et al. Among authors: wanner c. Nephrol Dial Transplant. 2002;17 Suppl 11:23-7. doi: 10.1093/ndt/17.suppl_11.23. Nephrol Dial Transplant. 2002. PMID: 12386253 Review.

3

Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients.

Wanner C, Krane V. Wanner C, et al. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S72-5. doi: 10.1053/ajkd.2003.50089. Am J Kidney Dis. 2003. PMID: 12612957 Review.

4

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics.

Wanner C, Krane V, März W, Olschewski M, Asmus HG, Krämer W, Kühn KW, Kütemeyer H, Mann JF, Ruf G, Ritz E; Deutsche Diabetes-Dialyse-Studie (4D) Study Group. Wanner C, et al. Kidney Blood Press Res. 2004;27(4):259-66. doi: 10.1159/000080241. Epub 2004 Aug 16. Kidney Blood Press Res. 2004. PMID: 15316128 Clinical Trial.

5

Alternative approach for rapid and reliable single-nucleotide polymorphism typing with double restriction mutagenesis primer PCR.

Berger M, Zschemisch S, Hocher B, Mönks D, Slowinski T, Halle H, Wanner C, Walter U, Lindner TH. Berger M, et al. Among authors: wanner c. Clin Chem. 2004 Dec;50(12):2376-8. doi: 10.1373/clinchem.2004.036137. Clin Chem. 2004. PMID: 15563486 No abstract available.

6

Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?

Krane V, Wanner C. Krane V, et al. Among authors: wanner c. Am J Kidney Dis. 2005 Mar;45(3):607-9. doi: 10.1053/j.ajkd.2005.01.011. Am J Kidney Dis. 2005. PMID: 15754285 No abstract available.

7

Sample sizes for clinical trials with time-to-event endpoints and competing risks.

Schulgen G, Olschewski M, Krane V, Wanner C, Ruf G, Schumacher M. Schulgen G, et al. Among authors: wanner c. Contemp Clin Trials. 2005 Jun;26(3):386-96. doi: 10.1016/j.cct.2005.01.010. Epub 2005 Apr 26. Contemp Clin Trials. 2005. PMID: 15911472

8

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators. Wanner C, et al. N Engl J Med. 2005 Jul 21;353(3):238-48. doi: 10.1056/NEJMoa043545. N Engl J Med. 2005. PMID: 16034009 Free article. Clinical Trial.

9

Hidden population substructures in an apparently homogeneous population bias association studies.

Berger M, Stassen HH, Köhler K, Krane V, Mönks D, Wanner C, Hoffmann K, Hoffmann MM, Zimmer M, Bickeböller H, Lindner TH. Berger M, et al. Among authors: wanner c. Eur J Hum Genet. 2006 Feb;14(2):236-44. doi: 10.1038/sj.ejhg.5201546. Eur J Hum Genet. 2006. PMID: 16333311

10

Lessons learnt from the 4D trial.

Wanner C, Krane V. Wanner C, et al. Nephrol Ther. 2006 Feb;2(1):3-7. doi: 10.1016/j.nephro.2006.01.002. Epub 2006 Feb 24. Nephrol Ther. 2006. PMID: 16895709 Clinical Trial. English, French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,050 results

Search Page

Filters